In 2021, ** percent of insurers in Latin America reported less than *** percent of insured members utilized telehealth for physician/GP services, while ** percent of insurers in the Asia Pacific region reported the same. Globally, only *** percent of insurers reported that ** percent or more insured people had utilized telehealth services in 2021.

Between April 2020 and March 2021, approximately ** percent of the Spanish population had a received medical consultation from a doctor online or by phone due to the pandemic, the highest share across all European Union countries. Slovenia ranked second on the list with ** percent of people in the country receiving a telemedicine consultation, followed by Poland at ** percent.

According to a survey carried out in Great Britain in 2021, ** percent of respondents overall agreed that telehealth is more time effective than in-person consultations. Furthermore, ** percent agreed that telehealth provides more accessibility to quality healthcare, however, ** percent indicated an unwillingness to use telehealth services post-COVID-19.

In 2021, ** percent of black respondents to a survey carried in the United States reported to have used telehealth visits in the last year. While, less than a quarter of Hispanic respondents had used telehealth in the last twelve months.

The National Ambulatory Medical Care Survey (NAMCS), conducted by the National Center for Health Statistics (NCHS), collects data from physician offices to describe practice characteristics and patterns of ambulatory care delivery in the United States. After the COVID-19 pandemic began, NCHS added questions to the 2020 and 2021 NAMCS Physician Induction Interview to evaluate physicians’ experiences related to the pandemic. Specifically, physicians in office-based settings were asked about: shortages of personal protective equipment (PPE); experiences with COVID-19 testing; providers in their office who tested positive for COVID-19; turning away COVID-19 patients; and telemedicine or telehealth technology use at their office. Measures related to these topic areas are further described and displayed in data dashboards here: https://www.cdc.gov/nchs/covid19/namcs.htm.

In March 2021, approximately ** percent of Americans surveyed reported that using telemedicine has made it easier to get the care they needed, while approximately ** percent of the respondents who reported being afraid of going to the doctor said their fears were eased during their experience with telehealth.

The National Ambulatory Medical Care Survey (NAMCS), conducted by the National Center for Health Statistics (NCHS), collects data on visits to physician offices to describe patterns of ambulatory care delivery in the United States. As part of NAMCS, the Physician Induction Interview collects information about practice characteristics at physician offices. Partway through the 2020 NAMCS, NCHS added questions to the Physician Induction Interview to assess physician experiences related to COVID-19 in office-based settings. The data include nationally representative estimates of experiences related to COVID-19 among office-based physicians in the United States, including: shortages of personal protective equipment (PPE) in the past 3 months; the ability to test for COVID-19 in the past 3 months; providers testing positive for COVID-19 in the past 3 months; turning away COVID-19 patients in the past 3 months; and telemedicine or telehealth technology use before and after March 2020. Estimates were derived from interviews with physicians in periods 3 and 4 of 2020 NAMCS and periods 1 through 4 of 2021 NAMCS, which occurred between December 15, 2020 and May 6, 2022. The data are considered preliminary, and the results may change with the final data release.

The Research and Development Survey (RANDS) is a platform designed for conducting survey question evaluation and statistical research. RANDS is an ongoing series of surveys from probability-sampled commercial survey panels used for methodological research at the National Center for Health Statistics (NCHS). RANDS estimates are generated using an experimental approach that differs from the survey design approaches generally used by NCHS, including possible biases from different response patterns and sampling frames as well as increased variability from lower sample sizes. Use of the RANDS platform allows NCHS to produce more timely data than would be possible using traditional data collection methods. RANDS is not designed to replace NCHS’ higher quality, core data collections. Below are experimental estimates of telemedicine access and use for three rounds of RANDS during COVID-19. Data collection for the three rounds of RANDS during COVID-19 occurred between June 9, 2020 and July 6, 2020, August 3, 2020 and August 20, 2020, and May 17, 2021 and June 30, 2021. Information needed to interpret these estimates can be found in the Technical Notes. RANDS during COVID-19 included questions about whether providers offered telemedicine (including video and telephone appointments) in the last 2 months—both during and before the pandemic—and about the use of telemedicine in the last 2 months during the pandemic. As a result of the coronavirus pandemic, many local and state governments discouraged people from leaving their homes for nonessential reasons. Although health care is considered an essential activity, telemedicine offers an opportunity for care without the potential or perceived risks of leaving the home. The National Health Interview Survey, conducted by NCHS, added telemedicine questions to its sample adult questionnaire in July 2020. The Household Pulse Survey (https://www.cdc.gov/nchs/covid19/pulse/telemedicine-use.htm), an online survey conducted in response to the COVID-19 pandemic by the Census Bureau in partnership with other federal agencies including NCHS, also reports estimates of telemedicine use during the pandemic (beginning in Phase 3.1, which started on April 14, 2021). The Household Pulse Survey reports telemedicine use in the last 4 weeks among adults and among households with at least one child under age 18 years. The experimental estimates on this page are derived from RANDS during COVID-19 and show the percentage of U.S. adults who have a usual place of care and a provider that offered telemedicine in the past 2 months, who used telemedicine in the past 2 months, or who have a usual place of care and a provider that offered telemedicine prior to the coronavirus pandemic. Technical Notes: https://www.cdc.gov/nchs/covid19/rands/telemedicine.htm#limitations

ABSTRACT Objective: to report on the creation and implementation of telehealth activities developed by the Forest Health Program in communities in conservation areas, in the state of Amazonas, during the COVID-19 pandemic. Methods: this is an experience report on the creation and implementation of the program. Results: the project began in June 2021 with medical and nursing services and currently has 63 points of connectivity installed. Dermatology was the most requested specialty (30.1%), with dermatitis being the main grievance diagnosed. For nursing, the most requested specialty was obstetrics, followed by pediatrics. Rio Madeira and the Catuá-Ipixema Extractive Reserve requested more than half of all consultations. Conclusion: this project showed a differentiated performance of telehealth in riverside communities in Amazonas, especially in the pandemic context, expanding health care in remote areas, such as these.

In 2022, nearly 26 percent of young adults surveyed in the U.S., aged between 18 and 29 had used telemedicine in the past year. Compared to 2021, the share of young adults who used telemedicine had decreased.

The global telehealth market size was estimated at USD 41.01 billion in 2021 and is predicted to surpass over USD 224.87 billion by 2030 and poised to reach at a CAGR of 18.81% during the forecast period 2022 to 2030.

global Telehealth Market size was USD 62.22 Billion in 2021 and is expected to register a revenue CAGR of 36.1% during the forecast period, Rapid technological advancements such as the latest upgraded healthcare monitoring apps, and wearable technology in the field of Telehealth services

The National Electronic Health Records Survey (NEHRS) is an annual survey of non-federally employed, office-based physicians practicing in the United States (excluding those in the specialties of anesthesiology, radiology, and pathology). NEHRS began in 2008 and was originally designed as an annual mail supplement to the National Ambulatory Medical Care Survey (NAMCS). Since 2012, NEHRS has been administered as a survey independent of NAMCS. Data from NEHRS can be used to produce state and national estimates of EHR adoption and capabilities, burden associated with EHRs, and progress physicians have made towards meeting the policy goals of the HITECH Act. In more recent years, survey questions have also asked about Promoting Interoperability programs, sponsored by the Centers for Medicare and Medicaid Services (CMS).

Electronic health record data from 217 primary care clinics were examined from January 1, 2019 to July 31, 2021. Data included telehealth and in-person visits for 759,138 adult patients (aged ≥18 years). Monthly rates of tobacco assessment per 1,000 patients were calculated. From March 2020 to May 2020, tobacco assessment monthly rates declined by 50% and increased from June 2020 to May 2021 but remained 33.5% lower than pre-pandemic levels. Rates of tobacco cessation assistance changed less, but remain low.

Abstract Introduction Since the new coronavirus (SARS-CoV-2) was declared a pandemic, health care was one of the fields that underwent significant changes. Telemedicine, that uses technological and communication resources to provide health care, was deemed a safe alternative to continue patient care while quarantine and social isolation measures were in place. Objective To analyze the perception of women treated at an outpatient clinic in relation to remote health care implemented during the COVID-19 pandemic. Methods Descriptive research conducted at the Women’s Physiotherapy Outpatient Clinic of the Prof. Fernando Figueira Comprehensive Medicine Institute (IMIP) in Recife, Pernambuco state, Brazil. The study included women above the age of 18 years who were being remotely treated and excluded those who discontinued treatment. Data were collected from November 2020 to July 2021, using a questionnaire which was sent to the participants via WhatsApp. Results Twenty-six women with an average age of 52 ± 10.1 years were interviewed. Most (61.54%) were being treated for urinary incontinence at the outpatient clinic and 38.5% had been undergoing physiotherapy for at least six months. A total of 92.3% of the participants reported feeling safe with remote health care and 70.4% noticed an improvement in their symptoms. Conclusion Most patients noticed an improvement in their symptoms, felt comfortable and safe with teleservices and would agree to continue even after returning to in-person care. However, to ensure more effective results, patients need to be well informed and have some prior knowledge about the proposed treatment.

In 2021 and 2022, the share of telehealth visits in the United States was higher among older patients. A quarter of over ** year olds had a telehealth visit in 2021 and 2022, compared to fewer than ** percent 18 to 24 year olds.

Electronic health record data from 203 community health centers across 13 states between 01/01/2019-6/31/2021 to describe trends in telemedicine visit rates over time. Qualitative data were collected from 13 of those community health centers to understand factors influencing adoption and implementation of telemedicine.

Telemedicine Market is Segmented by Type (Tele Hospitals, Tele Homes, and MHealth), Component (Products and Services), Mode of Delivery (On-Premises Delivery, Cloud-Based Delivery, and More), Deployment Model (Real-Time, Store-And-Forward, More), End User (Providers, Payers, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Aim: The aim of this systematic review and meta-analysis was to identify, evaluate, and synthesize the evidence from studies that have investigated the treatment effect via telemedicine interventions on depressive symptoms, quality of life, and work and social functioning in patients with depression. Methods: Six electronic databases (MEDLINE [1916–2021], PubMED [1950–2021], PsycINFO [1971–2021], Scopus [2004–2021], Embase [1972–2021], and CINAHL [1937–2021]) were systematically searched in March 2021. Reference lists of identified articles were hand searched. Randomized controlled trials were included if they investigated the treatment effects via telemedicine interventions in patients who had a depression diagnosis. Quality assessment was evaluated using the critical appraisal checklists developed by the Joanna Briggs Institute. Results: Seventeen (17) trials (n = 2,394) met eligibility criteria and were included in the analysis. Eleven (11) randomized controlled trials shared common outcome measures, allowing meta-analysis. The results provided evidence that treatment via telemedicine interventions were beneficial for depressive symptoms (standardized mean difference= −0.44; 95% CI= −0.64 to −0.25; p < .001) and quality of life (standardized mean difference= 0.25, 95% CI −0.01 to 0.49, p = .04) in patients of depression. There were insufficient data for meta-analysis of work and social functioning. Conclusion: This study showed the positive effects of treatment via telemedicine interventions on depressive symptoms and quality of life in patients with depression and supported the idea for clinical practice to establish a well-organized telepsychiatry system.KEY MESSAGESTelemedicine is effective at reducing symptoms of depression.Telemedicine can improve quality of life in persons with depression. Telemedicine is effective at reducing symptoms of depression. Telemedicine can improve quality of life in persons with depression.

The global telemedicine market size was USD 68.61 Billion in 2021, Increasing need for treatment and remote diagnosis of various chronic diseases such as diabetes, cancer, and heart diseases drives demand